Toward high-throughput drug screening on a chip-based parallel affinity separation platform

被引:5
作者
Ohlson, Sten [1 ]
Duong-Thi, Minh-Dao [1 ]
Bergstrom, Maria [1 ]
Fex, Tomas [2 ]
Hansson, Lennart [3 ]
Pedersen, Lennart [4 ]
Guazotti, Sergio [5 ]
Isaksson, Roland [1 ]
机构
[1] Linnaeus Univ, Sch Nat Sci, SE-39182 Kalmar, Sweden
[2] Astra&Zeneca AB, Molndal, Sweden
[3] Spago Imaging, Lund, Sweden
[4] Transient Interact AB, Loftahammar, Sweden
[5] Thermo Fisher Sci Inc, San Jose, CA USA
关键词
Albumin; Drug discovery; High-throughput screening; Weak affinity chromatography; Zonal affinity chromatography; HUMAN SERUM-ALBUMIN; LIQUID-CHROMATOGRAPHY; BINDING-SITES; CRYSTALLOGRAPHY; DISCOVERY;
D O I
10.1002/jssc.201000314
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
High-throughput screening of compound libraries, including the study of fragments, has become one of the cornerstones in modern drug discovery research. During this process hits are defined that may be developed into valuable leads and eventually into possible drug candidates. In this paper, we have demonstrated that parallel zonal weak affinity chromatography in microcolumns on a chip offers a possible screening format for weakly binding ligands toward a protein target. We used albumin as a model system because this transport protein is well established as a binder (both weak and strong) for drug substances. Bovine serum albumin was immobilized on microparticulate diolsilica particles and then packed into a 24-channel cartridge, which served as the separation platform. Analysis of the obtained chromatograms yielded information about affinity even in the millimolar range. Employing this approach, thousands of substances can be screened in just a day. We feel confident that zonal affinity chromatography will provide a useful technology in the future for performing high-throughput screening.
引用
收藏
页码:2575 / 2581
页数:7
相关论文
共 30 条
[1]   Ligand efficiency and fragment-based drug discovery [J].
Bembenek, Scott D. ;
Tounge, Brett A. ;
Reynolds, Chades H. .
DRUG DISCOVERY TODAY, 2009, 14 (5-6) :278-283
[2]   Cholera Toxin Inhibitors Studied with High-Performance Liquid Affinity Chromatography: A Robust Method to Evaluate Receptor-Ligand Interactions [J].
Bergstrom, Maria ;
Liu, Shuang ;
Kiick, Kristi L. ;
Ohlson, Sten .
CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 73 (01) :132-141
[3]   Exploration of Human Serum Albumin Binding Sites by Docking and Molecular Dynamics Flexible Ligand-Protein Interactions [J].
Deeb, Omar ;
Cecilia Rosales-Hernandez, Martha ;
Gomez-Castro, Carlos ;
Garduno-Juarez, Ramon ;
Correa-Basurto, Jose .
BIOPOLYMERS, 2010, 93 (02) :161-170
[4]   Evaluation of a glucose sensing antibody using weak affinity chromatography [J].
Engstrom, Henrik A. ;
Johansson, Reine ;
Koch-Schmidt, Per ;
Gregorius, Klaus ;
Ohlson, Sten ;
Bergstrom, Maria .
BIOMEDICAL CHROMATOGRAPHY, 2008, 22 (03) :272-277
[5]   Fragment-based drug discovery [J].
Erlanson, DA ;
McDowell, RS ;
O'Brien, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (14) :3463-3482
[6]   Structural basis of the drug-binding specificity of human serum albumin [J].
Ghuman, J ;
Zunszain, PA ;
Petitpas, I ;
Bhattacharya, AA ;
Otagiri, M ;
Curry, S .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 353 (01) :38-52
[7]   High-throughput drug discovery: what can we exulect from HTS? [J].
Gribbon, P ;
Sewing, A .
DRUG DISCOVERY TODAY, 2005, 10 (01) :17-22
[9]   Fragment-based screening using X-ray crystallography and NMR spectroscopy [J].
Jhoti, Harren ;
Cleasby, Anne ;
Verdonk, Marcel ;
Williams, Glyn .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2007, 11 (05) :485-493
[10]   FRONTAL AFFINITY-CHROMATOGRAPHY - THEORY FOR ITS APPLICATION TO STUDIES ON SPECIFIC INTERACTIONS OF BIOMOLECULES [J].
KASAI, K ;
ODA, Y ;
NISHIKATA, M ;
ISHII, S .
JOURNAL OF CHROMATOGRAPHY, 1986, 376 :33-47